BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19036151)

  • 1. Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study.
    de Vries MA; van Litsenburg RR; Huisman J; Grootenhuis MA; Versluys AB; Kaspers GJ; Gemke RJ
    Health Qual Life Outcomes; 2008 Nov; 6():103. PubMed ID: 19036151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired sleep affects quality of life in children during maintenance treatment for acute lymphoblastic leukemia: an exploratory study.
    van Litsenburg RR; Huisman J; Hoogerbrugge PM; Egeler RM; Kaspers GJ; Gemke RJ
    Health Qual Life Outcomes; 2011 Apr; 9():25. PubMed ID: 21496357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands.
    Schwartz ER; Rensen N; Steur LMH; Gemke R; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; Kaspers GJL; Van Litsenburg RRL
    BMJ Open; 2023 Oct; 13(10):e070804. PubMed ID: 37899146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
    Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
    Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses.
    Rensen N; Steur LMH; Grootenhuis MA; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Kaspers GJL; van Litsenburg RRL
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28697. PubMed ID: 32909677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
    Kunin-Batson A; Kadan-Lottick N; Neglia JP
    Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia.
    Steur LMH; Kaspers GJL; van Someren EJW; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; van Litsenburg RRL
    Support Care Cancer; 2020 Dec; 28(12):5983-5993. PubMed ID: 32285260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
    Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
    Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated intraocular pressure in children with acute lymphoblastic leukaemia: A prospective study.
    Barzilai-Birenboim S; Elitzur S; Nirel R; Ehrenberg M; Zahavi A; Avrahami G; Gabbay IE; Gilad G; Dotan G; Izraeli S; Daood RH; Geffen N
    Br J Haematol; 2022 Mar; 196(5):1248-1256. PubMed ID: 34862597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life Evaluation in patients receiving Steroids (the QuESt tool): initial development in children and young people with acute lymphoblastic leukaemia.
    Adams M; Robling M; Grainger J; Tomlins J; Johnson A; Morris S; Velangi M; Jenney M
    Arch Dis Child; 2016 Mar; 101(3):241-6. PubMed ID: 26699534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
    Petersen KB; Müller J; Rasmussen M; Schmiegelow K
    Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of quality of life during induction therapy in pediatric acute lymphoblastic leukemia.
    van Litsenburg RR; Huisman J; Pieters R; Verhaak C; Kaspers GJ; Gemke RJ
    Support Care Cancer; 2014 Dec; 22(12):3235-42. PubMed ID: 25011520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in children with acute lymphoblastic leukaemia.
    Jankowska-Polańska B; Sliwiński M; Świątoniowska N; Butrym A; Mazur G
    Scand J Caring Sci; 2020 Jun; 34(2):380-389. PubMed ID: 31334869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.
    Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE
    J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
    Rix M; Birkebaek NH; Rosthøj S; Clausen N
    J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in Japanese children with acute lymphoblastic leukemia during and after chemotherapy.
    Kobayashi K; Nakagami-Yamaguchi E; Hayakawa A; Adachi S; Hara J; Tokimasa S; Ohta H; Hashii Y; Rikiishi T; Sawada M; Kuriyama K; Kohdera U; Kamibeppu K; Kawasaki H; Oda M; Hori H
    Pediatr Int; 2017 Feb; 59(2):145-153. PubMed ID: 27422759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia.
    Warris LT; van den Akker EL; Aarsen FK; Bierings MB; van den Bos C; Tissing WJ; Sassen SD; Veening MA; Zwaan CM; Pieters R; van den Heuvel-Eibrink MM
    Psychoneuroendocrinology; 2016 Oct; 72():190-5. PubMed ID: 27448086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.